Efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Response to Grant et al

Letter/Communication

K M Gehrs

Diabetes care, Vol.24(1), pp.182-182

01/2001

DOI: 10.2337/diacare.24.1.182

PMID: 11194232

View Online

comment

Diabetic Retinopathy - drug therapy

Diabetic Retinopathy - pathology

Octreotide - therapeutic use

Humans

Randomized Controlled Trials as Topic

Title: Subtitle: Efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Response to Grant et al
Creators: K M Gehrs
Resource Type: Letter/Communication
Publication Details: Diabetes care, Vol.24(1), pp.182-182
DOI: 10.2337/diacare.24.1.182
PMID: 11194232
NLM abbreviation: Diabetes Care
ISSN: 0149-5992
eISSN: 1935-5548
Publisher: United States
Language: English
Date published: 01/2001
Academic Unit: Ophthalmology and Visual Sciences
Record Identifier: 9983980297702771

26 Record Views